The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-16
DOI
10.1186/s13195-020-00652-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
- (2019) Carla M. Startin et al. Alzheimers Research & Therapy
- Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
- (2019) Omar A. Halawa et al. Alzheimers Research & Therapy
- Tissue Cytokine IL-33 Modulates the Cytotoxic CD8 T Lymphocyte Activity During Nutrient Deprivation by Regulation of Lineage-Specific Differentiation Programs
- (2019) Caroline Dreis et al. Frontiers in Immunology
- Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
- (2019) Woo Shik Shin et al. Alzheimers Research & Therapy
- Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study
- (2019) Tsai et al. Journal of Clinical Medicine
- IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment
- (2019) Josy Augustine et al. Journal of Neuroinflammation
- CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
- (2019) Samir Abu-Rumeileh et al. Alzheimers Research & Therapy
- Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development
- (2018) Ilia D. Vainchtein et al. SCIENCE
- Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
- (2018) Roger N. Rosenberg et al. Alzheimers Research & Therapy
- IL-33 in clinical practice: Size matters?
- (2017) Hideaki Morita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls
- (2017) Pei-Shen Ho et al. PSYCHIATRY RESEARCH
- Role of neuroinflammation in neurodegeneration: new insights
- (2017) Róisín M. McManus et al. Alzheimers Research & Therapy
- Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
- (2017) C Carlock et al. Translational Psychiatry
- Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
- (2017) Francesca La Rosa et al. Scientific Reports
- IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline
- (2016) Amy K. Y. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice
- (2016) Jian-Hui Wang et al. Alzheimers Research & Therapy
- High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
- (2016) Malin Degerman Gunnarsson et al. Alzheimers Research & Therapy
- Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury
- (2015) Yuriy Pomeshchik et al. BRAIN BEHAVIOR AND IMMUNITY
- Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation
- (2015) Paula Korhonen et al. BRAIN BEHAVIOR AND IMMUNITY
- Immune attack: the role of inflammation in Alzheimer disease
- (2015) Frank L. Heppner et al. NATURE REVIEWS NEUROSCIENCE
- The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury
- (2015) Sachin P. Gadani et al. NEURON
- A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram
- (2015) Pei-Shen Ho et al. PSYCHONEUROENDOCRINOLOGY
- The dynamics of monocytes and microglia in Alzheimer’s disease
- (2015) Peter Thériault et al. Alzheimers Research & Therapy
- Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
- (2014) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer’s disease model
- (2014) Shuang Wang et al. Alzheimers Research & Therapy
- Cerebral inflammation is an underlying mechanism of early death in Alzheimer’s disease: a 13-year cause-specific multivariate mortality study
- (2014) Katarina Nägga et al. Alzheimers Research & Therapy
- Sustained Interleukin-1 Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
- (2013) S. Ghosh et al. JOURNAL OF NEUROSCIENCE
- Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
- (2012) Rachel F Lane et al. Alzheimers Research & Therapy
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF- B To Dampen NF- B-Stimulated Gene Transcription
- (2011) S. Ali et al. JOURNAL OF IMMUNOLOGY
- Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
- (2009) J Chapuis et al. MOLECULAR PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation